MedLab Middle East Continues as World's Largest Attended Laboratory Exhibition and Conference
By LabMedica International staff writers Posted on 05 Feb 2018 |

Image: MEDLAB Middle East continues to be the largest attended laboratory and IVD exhibition and conference in the world (Photo courtesy of MEDLAB).
MEDLAB Middle East, held a week after Arab Health, continued to be the largest attended laboratory and IVD exhibition and conference in the world. Held from February 5-8, 2018, the annual laboratory meeting saw its second year as a stand-alone show and welcomed over 600 exhibitors and more than 25,000 attendees from 129+ countries.
MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the US. As the largest attended laboratory expo worldwide, MEDLAB stems from 15 years of growth alongside the MENA region's largest healthcare gathering, Arab Health.
MEDLAB Middle East held in Dubai, UAE, continued to expand in 2018 with the addition of two new halls and the capacity to showcase thousands of new products, equipment and services by the main players in the industry. Leading laboratory experts, scientists, researchers and clinicians converged at the three-day event to exchange and share their experiences and research results on all aspects of laboratory medicine and clinical research while companies showcased the latest innovations, products and cutting-edge technologies available in the IVD, medical laboratory and healthcare market.
At the heart of MEDLAB laboratory conference and exhibition lies the CME-accredited Congress featuring 17 CME-accredited conference tracks. Supported by the Cleveland Clinic, the MEDLAB conferences provide professionals with high-level CME credits. The MEDLAB Conferences cover a diverse range of subjects relating to laboratory management, microbiology, immunology, hematology, clinical chemistry and molecular diagnostics. With over 6,500 conference delegates in attendance from all over the world, the MEDLAB Congress is the ideal platform to come together and discover innovations in medical laboratory testing. MEDLAB Congress 2018 introduced new clinical tracks designed to enhance collaboration between laboratory professionals and clinicians. This will aid in accurate interpretation, quick reporting and diagnosis, therefore strengthening the laboratory’s ability to provide clinical decisions and improve the overall quality of service and care.
This year’s MEDLAB Middle East also featured the Obs-Gyne Exhibition, which provided a platform for over 2,500 obstetricians, gynecologists, fertility specialists and family physicians to gather alongside 60+ of the industry's leading manufacturers to meet, exchange knowledge, share best practices and ultimately improve the level of patient care provided. Some of the key topics of discussion at the Obs-Gyne Exhibition were postpartum hemorrhage, androgen disorders in adolescents, psychological and sexual aspects in female genital cancer, early prediction and prevention of pre-eclampsia, obesity in pregnancy, treatment options for infertile women with uterine fibroids, and monitoring and delivery of the growth of restricted fetus.
The Poster Zone at the event displayed the latest research from laboratorians worldwide, promoting knowledge sharing and networking amongst MEDLAB’s delegates, who discussed the latest research, findings and developments within the industry. The Workshop Zone featured workshops hosted by leading laboratory and diagnostic companies who provided a hands-on approach towards utilizing the latest testing methods, findings and technology. MEDLAB Middle East also welcomed dealers and distributors from across the region as well as representatives from hospitals, consultancies and governments who took the opportunity to meet, do business with exhibitors and learn from all professionals within the healthcare and medical laboratory marketplace.
Latest MEDLAB 2018 News
- Snibe Diagnostic Displays Analyzers at MEDLAB Europe 2018
- MEDLAB Europe 2018 Presents Latest Technologies and Developments
- Fujifilm Showcases DRI-CHEM NX700 Dry Chemistry Analyzer
- Zeesan Biotech Displays DNA Automated Extraction System
- Priorclave Highlights Its Smallest Steam Sterilizer
- HORIBA Medical Launches HELO and Yumizen G Range
- Astell Scientific Showcases Latest Autoclave Range
- AXA Diagnostics Highlights SkyLAB752 System
- Block Scientific Showcases Medical Lab Equipment Devices
- BIOBASE Displays Range Of Laboratory & Medical Analyzers
- EKF Diagnostics Showcases Latest Data Management Solutions
- Siemens Healthineers Showcases Advanced Diagnostics Analyzers
Channels
Clinical Chemistry
view channel
Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse
Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more
‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection
Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more
Low-Cost Portable Screening Test to Transform Kidney Disease Detection
Millions of individuals suffer from kidney disease, which often remains undiagnosed until it has reached a critical stage. This silent epidemic not only diminishes the quality of life for those affected... Read more
New Method Uses Pulsed Infrared Light to Find Cancer's 'Fingerprints' In Blood Plasma
Cancer diagnoses have traditionally relied on invasive or time-consuming procedures like tissue biopsies. Now, new research published in ACS Central Science introduces a method that utilizes pulsed infrared... Read moreMolecular Diagnostics
view channel
Genetic-Based Tool Predicts Survival Outcomes of Pancreatic Cancer Patients
A tumor marker is a substance found in the body that may signal the presence of cancer. These substances, which can include proteins, genes, molecules, or other biological compounds, are either produced... Read more
Urine Test Diagnoses Early-Stage Prostate Cancer
Prostate cancer is one of the leading causes of death among men worldwide. A major challenge in diagnosing the disease is the absence of reliable biomarkers that can detect early-stage tumors.... Read moreHematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read moreImmunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read moreMicrobiology
view channel
New Test Diagnoses Bacterial Meningitis Quickly and Accurately
Bacterial meningitis is a potentially fatal condition, with one in six patients dying and half of the survivors experiencing lasting symptoms. Therefore, rapid diagnosis and treatment are critical.... Read more
Handheld Device Delivers Low-Cost TB Results in Less Than One Hour
Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read morePathology
view channel
AI-Based Model Predicts Kidney Cancer Therapy Response
Each year, nearly 435,000 individuals are diagnosed with clear cell renal cell carcinoma (ccRCC), making it the most prevalent subtype of kidney cancer. When the disease spreads, anti-angiogenic therapies... Read more
Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation
Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read moreTechnology
view channel
Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses
Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more
Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples
As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more
Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples
Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read moreIndustry
view channel
Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions
Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more